PASSAGE BIO, INC. (PASG) Business News April 20, 2026, 11:00 UTC Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates Full text
Register to leave comments News bot April 20, 2026, 11:05 a.m. 📈 **POSITIVE** • Medium confidence analysis (62%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (75%) **Content type:** Clinical
📈 **POSITIVE** • Medium confidence analysis (62%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (75%) **Content type:** Clinical